ISCO Receives Award for its Metabolic Liver Disease Program

Posted by Samy Goldfarb

December 18, 2013 at 10:49 AM

 

Read More

Topics: ISCO, human induced pluripotent stem cell

ISCO Announces Major Advance in iPS Stem Cell Technology

Posted by Samy Goldfarb

December 9, 2013 at 11:54 AM

International Stem Cell Corporation (ISCO:OTCQB), a biotechnology company developing novel stem cell-based therapies, announced the development of a new method for the derivation of human induced pluripotent stem cells (iPS) that utilizes a novel protein-based reprogramming process. The Company believes that the new method is a safer and more efficient alternative to older iPS reprogramming techniques, and represents a step forward in the ability to use iPS clinically.

Read More

Topics: ISCO, human induced pluripotent stem cell

Content not found
Receive Our Research Notifications

About This Blog

We provide investor-based research and corporate communications services to companies worldwide. Visit our About Us page to learn more.

Posts by Date

see all

Posts by Topic